Introduction
The function of eukaryotic membranes reflects their lipid composition as much as that of proteins, and yet the mechanisms by which lipid partitioning is maintained are largely unknown. Niemann Pick type C (NP-C) disease is a neurodegenerative lipid storage disorder, the accepted biochemical hallmark of which is the lysosomal accumulation of low density lipoprotein (LDL)-derived unesterified cholesterol. Consequently, the reactions responsible for sterol biosynthesis, uptake, and esterification are misregulated (Pentchev et al., 1997) . Although the defect in cholesterol egress from the endosomal-lysosomal (E-L) system is the predominant cellular phenotype, NP-C disease is further typified by the subcellular accumulation of complex glycosphingolipids (Vanier, 1999) . Moreover, fibroblasts from a "variant" subgroup of NP-C individuals with profound neurodysfunction exhibit severe sphingolipid transport aberrancies but modest cholesterol mislocalization (Sun et al., 2001) . Subcellular protein transport does not appear to be altered in NP-C gene 1 ( NPC1 )-defective cells; however, markers of endocytosis exhibit retarded transport to extralysosomal sites .
A positional cloning approach identified the NPC1 gene as defective in 95% of patients with NP-C disease . NPC1 predicts a glycosylated, transmembrane protein with a similarity to the morphogen receptor Patched (Ptc, 23% identity) and the sterol regulatory element-binding protein (SREBP) cleavage-activating protein (SCAP), a protein integral to sterol and fatty acid homeostasis (26% identity over 190 residues; Fig. 1 ). The latter conservation corresponds to a putative sterol-sensing domain (SSD). NPC1 is ubiquitously and constitutively expressed in mammalian tissues and is conserved from yeast to humans . In contrast, many aspects of receptor-mediated uptake of sterol are absent over the same period of evolution, suggesting a primordial function of the Npc1 protein family that predates exogenous sterol transport. We demonstrate that the NP-C-related gene 1 ( NCR1 ), the yeast orthologue of mammalian NPC1 , performs a conserved function that is distinct from trafficking of sterol. We show that in mammalian cells the proteins are interchangeable with respect to cholesterol and ganglioside transport, and yet a null mutation in yeast NCR1 has no sterol-related phenotype. A dominant mutation in the SSD of yeast NCR1 confers pleiotropic phenotypes consistent with altered sphingolipid transport. We propose that in this ancestral eukaryote, the role of NPC1-like proteins is to recycle sphingolipids and that in multicellular organisms, one consequence of this is transport of cholesterol.
Results
Yeast NCR1 , an orthologue of human NPC1 The predominant sterol of Saccharomyces cerevisiae is ergosterol, which is synthesized, esterified, used, and regulated in a similar manner to cholesterol in mammals (Sturley, 2000) . Subcellular sterol transport may also be conserved between yeast and mammalian cells; Ncr1p (YPL006w) is an uncharacterized 1,170-residue transmembrane protein with a signal peptide, eight N-glycosylation sites, and 35% identity to the human Npc1 protein. As for Npc1p, Ncr1p is structurally similar to Ptc and the SSD of SCAP (Fig. 1) , and furthermore, identical to the normal NPC1 allele at many residues implicated in NP-C disease (Greer et al., 1999; Ribeiro et al., 2001) . These alleles include G 897 and I 972 in Ncr1p, corresponding to two common NP-C disease alleles (G 992 W and I 1061 T, respectively). Overall, the molecules are compellingly similar.
Expression of yeast NCR1 complements loss of NPC1
To test the functional equivalence of the yeast and human proteins, we expressed NCR1 in CHO CT60 and NPC1-trap cells lacking Npc1 (Cruz et al., 2000; Higaki et al., 2001) . Yeast proteins lack targeting information for mammalian endosomes. Because Npc1p localization, which is mediated by COOH-terminal motifs is required for full complementation (Watari et al., 1999; Ioannou, 2000) , we fused the last 64 residues of human NPC1 to Ncr1p ( NCR1-Cterm ). Expression constructs for NCR1 and NCR1-Cterm were transfected into the CHO cells, and sterol transport was assessed by filipin staining and fluorescence microscopy. Expression of NCR1-Cterm restored cholesterol clearance to levels indistinguishable from cells expressing human NPC1 (Fig.  2 and Table I ). A significant decrease in E-L filipin staining was also observed upon expression of NCR1 . Although fewer filipin negative cells were observed, most transfected cells displayed "partial" clearance of cholesterol. This diminished suppression likely reflects mislocalization of the native yeast protein; a GFP fusion with Ncr1p localizes to the early endosome, whereas NCR1-Cterm-GFP was detected in the late endosomal compartment (unpublished data).
The subcellular accumulation of sphingolipids, particularly gangliosides, is another characteristic of the NP-C syndrome, and in the case of GM1 has been observed in NPC1-deficient CHO cells ). Expression of NCR1-Cterm or human NPC1 reversed the accumulation of GM1 in the E-L compartment of transfected CT60 cells as detected by fluorescent cholera toxin (subunit B) binding assays (Fig. 2 B) . Thus, when provided with the correct localization motif, the yeast and human proteins function interchangeably, suggesting a conserved activity despite several billion years of divergence.
Null mutations in yeast NCR1 have no effect on sterol metabolism In mammalian cells lacking NPC1, exogenous sterol is sequestered from the esterification reaction and sterol biosynthesis is misregulated. During anaerobic growth (Gollub et al., 1974) or in upc2-1 mutants (Lewis et al., 1988) , sterol is absorbed by yeast in an ABC-transporter-dependent process (Wilcox et al., 2002) and esterified by the acylCoA choles- (Fig. 1 B) were assessed for growth or metabolic incorporation (percent incorporation Ϯ SEM) under the conditions described. The growth of the normal strain is considered ϩϩ and the growth of the other strains is expressed relative to that scale.
terol acyltransferase orthologues (Yang et al., 1996) . Deletion of NCR1 had no effect on acetate incorporation into sterols, oleate incorporation into steryl esters, anaerobic viability, or esterification of exogenous [ 14 C]cholesterol (Table  II) . Cell sterol composition can be exaggerated by deletion of ERG6 (C-24 sterol methyl transferase; Gaber et al., 1989) or ERG9 (squalene synthase; Fegueur et al., 1991) or treatment with zaragozic acid, an inhibitor of squalene synthase (Bergstrom et al., 1993) . This exaggeration results in membrane perturbations and, in the latter two cases, sterol auxotrophy; however, loss of NCR1 in these contexts had no effect on cell viability or sterol uptake (unpublished data).
In contrast to observations with NP-C mutant fibroblasts ( Fig. 2 A) , the majority of sterol in ncr1⌬ and normal yeast strains detected by filipin fluorescence resides at the plasma membrane ( Fig. 3 A) . In validation of the assay, arv1 strains that accumulate sterols in subcellular membranes (Tinkelenberg et al., 2000) displayed significant subcellular filipin staining, whereas an erg6 mutant had barely detectable plasma membrane fluorescence. Moreover, ncr1⌬ strains displayed no changes in sensitivity to polyene antibiotics (e.g., nystatin) that form lethal complexes with ergosterol. Finally, the relative distribution of sterols and phospholipids across a subcellular fractionation was unchanged in ncr1⌬ mutants (Fig. 3  B) , further suggesting that membrane composition, particularly with respect to sterol, was unaffected by loss of NCR1.
Normal and ncr1⌬ strains grew comparably on a variety of carbon sources and at different temperatures (12Њ, 30Њ, 38Њ, and 40ЊC). Similarly, there was no growth differential due to supplementation with 1 M sorbitol or 0.75 M NaCl (Table  II) . A transmembrane permease activity with specificity for oleic acid and acriflavine has been suggested for Npc1p (Davies et al., 2000) . However, we could detect no defect in uptake of [ 3 H]oleate or in accumulation of acriflavine in ncr1 mutants (unpublished data). In a further attempt to reveal a phenotype due to loss of NCR1, we undertook a transcriptional profiling approach. Oligonucleotide arrays (Affymetrix) were used to compare normal and ncr1⌬ strains. Consistent with the redundancy of NCR1, there were no significant (i.e., greater than twofold) transcriptional differences between these strains (unpublished data). In summation, the deletion of NCR1 had no detectable physiological consequences.
Expression and localization of Ncr1p
The NCR1 gene is transcribed (Fig. 4 A) and expressed in normal strains and growth conditions as evidenced by tagging the endogenous protein with the HA epitope NCR1-HA. The biological activity of this allele was confirmed in the NPC1 mutant CHO cells (unpublished data). Ncr1-HAp was detected as a membrane-associated, endoglycosidase H-sensitive glycoprotein ‫031ف(‬ kD; Fig. 4 B) , indicating its passage through the ER. In a further example of concordance between the yeast and human proteins, Ncr1-HAp cofractionated predominantly with normal yeast vacuoles, the equivalent organelle to the E-L system of mammalian cells (Fig. 4 C) . Furthermore, a GFP-Ncr1 fusion protein localizes to the vacuolar membrane (Huh et al., 2003; unpublished 
data).
A dominant mutation in the SSD of yeast NCR1 Ncr1p is biologically active when expressed in mammalian cells, and yet loss of Ncr1p is of no apparent consequence in yeast. To bypass this redundancy, we introduced mutations in NCR1 (Fig. 1 B) analogous to dominant mutations in the SSD of SCAP (Nohturfft et al., 1998) . The presence of asparagine instead of aspartic acid at residue 443 in SCAP confers sterol-resistant SREBP cleavage; thus, we mutated the analogous residue (Tyr718) of Ncr1p to either aspartic acid (NCR1Y 718 D) or asparagine (NCR1Y 718 N). In addition, we changed an invariant tyrosine of the Ncr1p SSD (Tyr571) to cysteine (NCR1Y 571 C). The mutations were introduced at the NCR1 locus by homologous recombination and did not affect NCR1 transcript levels (Fig. 4 A) .
Because the NCR1Y 571 C, NCR1Y 718 D, and NCR1Y 718 N mutations reside in a putative SSD, we anticipated an alter- ation in sterol metabolism. NCR1Y 718 D strains, unlike the others, were hypersensitive to nystatin, suggestive of perturbed plasma membrane properties (Fig. 5 A) . However, anaerobic growth, an indicator of exogenous sterol transport, was unaltered relative to aerobic growth (Table II) . Furthermore, sterol synthesis, esterification (Table II) , and localization (Fig. 3 A; and see Fig. 7 C) were not significantly different in these strains compared with normal strains. The NCR1Y 718 D allele conferred poor growth at 30ЊC, inviability at 38ЊC (Fig. 5 A) , and salt sensitivity and poor growth on carbon sources such as acetate and ethanol (Table II) . The NCR1Y 718 N and NCR1Y 571 C, strains were modestly impaired at elevated temperatures (Fig. 5 A) , but were otherwise indistinguishable from normal strains. The NCR1Y 718 D strains were not uniformly sick; responses to sorbitol, calcium, hydroxyurea, and low pH were indistinguishable from growth on YPD at 30ЊC (Table II) .
Yeast strains with the NCR1Y 718 D mutation exhibit pleiotropic phenotypes, whereas the ncr1⌬ strain showed no defects, predicting that this variant would act as a dominant allele. Normal, ncr1⌬, and NCR1Y 718 D strains were transformed with vector control or a plasmid carrying NCR1. NCR1 expression was confirmed by RT-PCR assays (not depicted) but failed to rescue inviability at 38ЊC of the NCR1Y 718 D strains (Fig. 5 B) . In addition, heterozygous NCR1/NCR1Y 718 D diploids retain the temperature sensitivity of the NCR1Y 718 D allele, further indicating dominant inheritance (unpublished data).
The NCR1Y 718 D allele alters sphingolipid metabolism NP-C disease is characterized by sphingolipid accumulation. Furthermore, the sensitivity of yeast to temperature, high salt, or polyenes can result from modulations in sphingolipids (Dickson and Lester, 2002) . Thus, in the absence of a sterol-related phenotype, we questioned whether or not sphingolipid metabolism was disturbed by mutations in NCR1. In S. cerevisiae, ceramide is synthesized from phytosphingosine and is the precursor for synthesis of inositolphosphorylceramide (IPC), mannosyl-IPC (MIPC), and mannosyl-di-IPC (M(IP) 2 C). These complex sphingolipids are analogous to mammalian sphingolipids in that they associate with sterols in the plasma membrane and perform a critical role in membrane function (Dickson and Lester, 2002) . Normal yeast strains are sensitive to sphingosine and C2-ceramide (Nickels and Broach, 1996; Chung et al., 2001) . The NCR1Y 718 D mutant strain was super sensitive to 10 M C2-ceramide (Fig. 5 A) and 5 M sphingosine (Fig. 5 C) compared with the other strains. This phenotype was evident as a prolonged lag phase, which is consistent with retarded nutrient uptake, a trait common to alterations in sphingolipids (Chung et al., 2001) .
Changes in sphingolipid status can also be monitored using antifungals such as aureobasidin A (ABA), which blocks synthesis of IPC causing ceramide accumulation and inviability (Nagiec et al., 1997) . NCR1Y 718 D strains were resistant to 500 ng/ml ABA, whereas normal and ncr1⌬ strains were sensitive (Fig. 5 C) . ABA resistance was associated with increased incorporation of [ 3 H]dihydrosphingosine (DHS) into IPC at the expense of ceramide over a range of drug concentrations (Fig. 5 D) , which is consistent with increased flux through the sphingolipid biosynthetic pathway of NCR1Y 718 D strains.
The sensitivity of the NCR1Y 718 D strain to sphingosine and C2-ceramide, and resistance to ABA, led us to assess metabolic incorporation of [ 3 H]DHS into sphingolipids in the mutant strains over a 2-h labeling period (Fig. 6 ). The (CSG1 and CSG2) . RNA was extracted, resolved, transferred to nitrocellulose membranes by conventional methods, hybridized with CSG1 or CSG2 probes, and analyzed using a phosphorimager (arbitrary units, means Ϯ SEM). Deletion strains csg1⌬ and csg2⌬, respectively, for CSG1 and CSG2 acted as hybridization controls. Actin message levels were comparable between strains (not depicted). (C) The stress induction of ceramide synthesis in NCR1 mutants. Cultures of the indicated genotype were grown to exponential phase, split, and grown for a further 2 h in the presence of [ 3 H]DHS at 30 or 38ЊC. Incorporation of label was normalized to total incorporation into all lipids, which was equivalent at both temperatures (e.g., for normal strains, 2.53 and 2.19 ϫ 10 6 , cpm at 30 and 38ЊC, respectively). *, P Ͻ 0.01. levels of ceramide were comparable between the strains. However, NCR1Y 718 D strains accumulated 2.8-fold more MIPC (23.3% vs. 8.1%, P Ͻ 0.01%) and significantly less IPC and M(IP) 2 C (Fig. 6 A) . No changes in sphingolipids were observed in the other NCR1 mutants (unpublished data). Given the elevated MIPC levels in NCR1Y 718 D strains, we assessed the expression of CSG1, CSG2 (encoding components of MIPC synthase), and IPT1 (mediating the synthesis of M(IP) 2 C). CSG2 transcript levels were elevated in NCR1Y 718 D strains (Fig. 6 B) .
Upon heat shock, yeast elevate ceramide levels (Jenkins et al., 1997) . To assess if the temperature sensitivity of the NCR1Y 718 D strains was related to sphingolipid metabolism, we monitored the changes in ceramide levels of normal, ncr1⌬, and NCR1Y 718 D strains upon shifting to 38ЊC and labeling with [ 3 H]DHS. Ceramide levels increased fourfold in normal and ncr1⌬ strains upon temperature shift, whereas NCR1Y 718 D strains showed less than a twofold increase (Fig. 6 C) . Complex sphingolipids were not altered by heat shock relative to growth at 30ЊC. The molecular mechanism or purpose for increased de novo synthesis of ceramide after heat stress is not known, however, the diminished response by the NCR1Y 718 D strains may explain their compromised growth rates.
The NCR1Y 718 D mutation causes sphingolipid mislocalization In NPC1-deficient mammalian cells, the primary defect in sphingolipid metabolism relates to transport out of the E-L system (Choudhury et al., 2002) . To assess whether the recycling of complex sphingolipids through the yeast endosomal pathway might be disturbed by mutations in NCR1, we labeled sphingolipids to steady state by incubation for 18 h with [
3 H]DHS and subjected membranes to subcellular fractionation to separate plasma membranes from subcellular organelles (Fig. 7) . Before fractionation, it is clear that in NCR1Y 718 D strains MIPC accumulates at the expense of M(IP) 2 C, which is consistent with diversion of the former molecule from a biosynthetic pool (Fig. 7 A) . In normal strains, MIPC and M(IP) 2 C accumulate in the plasma membrane (Fig. 7, fractions 8-10) , colocalizing with the plasma membrane ATPase (Pma1p). We could detect no differences in the distribution of DHS metabolites in ncr1⌬ strains (unpublished data). However, in the NCR1Y 718 D strains, MIPC, and to a lesser extent M(IP) 2 C, redistributed to subcellular organelles, particularly the vacuolar compartment as inferred by colocalization with the vacuolar H ϩ -ATPase (Figs. 7, B and D, Vph1p) . Indeed, if we consider fractions 4 and 5 (Fig. 7) , in which Vph1p is predominant but Pma1p or Dpm1p are low, NCR1Y 718 D causes a 6.5-and 7.2-fold accumulation of MIPC relative to controls. This lipid rearrangement in the NCR1Y 718 D strains was specific to complex sphingolipids. The subcellular distribution of ceramide (Fig. 7 B) , phospholipids, and sterols (Fig. 7 C) was similar between strains.
Discussion
Niemann Pick disease type C is a neurodegenerative disorder with a significant defect in subcellular transport of exogenous sterols. However, NP-C disease is not solely a cholesterol storage disorder, and the nature of the offending metabolite in this syndrome is contentious, particularly in the brain. Sterol accumulation is detectable in NPC1-deficient neurons, but is not as striking as at extra-neuronal sites. Several works in genetically modified murine models of this disease have concluded that sterol uptake has no role in symptom development (Xie et al., 2000a,b) . In contrast, the metabolism and transport of sphingolipids is aberrant in most npc1 Ϫ/Ϫ cells, including neurons Zervas et al., 2001a; Zhang et al., 2001) . Finally, pharmacological intervention in sphingolipid synthesis alleviates symptoms in animal models of NP-C disease, whereas reductions in plasma cholesterol give no benefit (Patterson et al., 1993; Zervas et al., 2001b) .
What does the yeast system inform regarding the human syndrome? Despite evolutionary divergence, the yeast and mammalian proteins are functionally equivalent for sterol and ganglioside transport in mammalian cells. However, we failed to identify any defect in sterol metabolism conferred by mutations in NCR1. Thus, we hypothesize that Ncr1p performs a primordial function that underlies the sterol transport defects associated with NP-C disease. However, a quandary remains: what is the physiological role of this protein in yeast? The similarities of yeast Ncr1p and human Npc1p to the SREBP cleavage-activating protein led us to create constitutive mutations in the SSD of Ncr1p. One such allele, NCR1Y 718 D, functioned as a dominant neomorph, its most salient phenotype being the errant subcellular accumulation of MIPC. The normal pathways of sphingolipid distribution (Fig. 8) commence with synthesis of ceramide in the ER and transport to the Golgi compartment where complex sphingolipid synthesis progresses (Funato et al., 2002) . An asymmetry is then created; MIPC and M(IP) 2 C accumulate in the plasma membrane, whereas IPC localizes to the vacuole. In the NCR1Y 718 D strains, the sequestration of MIPC in the vacuole limits its retrograde movement to the Golgi compartment resulting in reduced M(IP) 2 C synthesis. The same event likely results in up-regulation of biosynthesis, in part at the level of transcription of the CSG2 gene. This increased flux explains resistance to pathway inhibitors, sensitivity to substrates such as C2-ceramide and sphingosine, and inadequate response to heat shock in terms of ceramide accumulation.
Based on these observations, we propose that the primordial role of the Npc1 protein family lies in sphingolipid recycling with sterol movement as a consequence, which is consistent with studies of NPC1 in mammalian cells (Coxey et al., 1993; Sugimoto et al., 2001) and with hypotheses that neurodegeneration in NP-C disease results from ganglioside accumulation. There are many precedents for a link between sphingolipid and sterol homeostasis. Multiple sphingolipid storage disorders are associated with perturbations in cholesterol homeostasis (Pagano et al., 2000) , perhaps because the two molecules readily form membrane microdomains (Bagnat et al., 2000; Simons and Ehehalt, 2002) . Indeed, cholesterol accumulation was strikingly reduced when NPC1 deficiency was combined with loss of the ␤-1-4GalNAc transferase responsible for complex ganglioside synthesis Gondre-Lewis et al., 2003) .
The SCAPs of mammals and insects via the SSDs are proposed to respond to membrane perturbations rather than changes in a specific molecule (Seegmiller et al., 2002) . It is clear that residue 443 of SCAP is a critical position in the SSD (Nohturfft et al., 1996) . Our work confirms this in a different protein (Ncr1p) and illustrates a clear species and molecule specificity. In mammalian SCAP, insect SCAP (Seegmiller et al., 2002) , or yeast Ncr1p, the normal residue is aspartic acid, asparagine, or tyrosine, respectively. In mammalian SCAP or yeast Ncr1p, substitution with asparagine or aspartic acid produce dominant phenotypes, which is likely due to the loss of specific protein-protein interac- Ceramide is synthesized in the ER and transported by vesiculardependent (1) and -independent (1a) pathways to the Golgi compartment. Conversion to complex sphingolipids (IPC, MIPC, and M(IP) 2 C) is followed by migration from the Golgi apparatus to the plasma membrane (2) or to vacuoles (3). In the sphingolipid recycling pathway, transport from the plasma membrane to vacuoles (4), or from vacuoles to the plasma membrane or the Golgi compartment (5 or 6), is selective between sphingolipids. Thus, in normal yeast, IPC accumulates in vacuoles, whereas M(IP) 2 C and to a lesser extent MIPC accumulate in the plasma membrane. In NCR1Y 718 D strains, recycling is disturbed such that MIPC and M(IP) 2 C accumulate in the vacuole. The sequestration of MIPC results in diminished M(IP) 2 C synthesis and up-regulation of biosynthesis of MIPC from IPC. tant phenotype, it is tempting to speculate they may interact with Ncr1p.
One model for the failure to identify an ncr1 null phenotype could be that the protein functions in a redundant pathway for sphingolipid recycling. Accordingly, NCR1Y 718 D acts as a dominant mutant that corrupts mutually redundant pathways of sphingolipid recycling, thus revealing a phenotype. The manipulation of these bypass pathways would be obvious targets to circumvent the transport defects and thus treat NP-C disease. Interestingly, overexpression of certain Rab proteins implicated in vesicular transport suppresses loss of NPC1 (Choudhury et al., 2002; Walter et al., 2003) . Whether or not this is an avenue to therapy remains to be determined; however, the identification of such bypass pathways in yeast and humans will provide a significant step in this direction.
Materials and methods

General
Standard methods were used for yeast manipulation (Ausubel et al., 1998) . Yeast strains are isogenic with W303-1A (Thomas and Rothstein, 1989) . Cholesterol, ergosterol, and nystatin were added from stock solutions (5 and 2 mg/ml in 1:1, ethanol/tyloxapol [Sigma-Aldrich] and 10 mg/ml in propylene glycol, respectively). Zaragosic acid (provided by Y.S. Chao, Merck & Co., Rahway, NJ), sphingosine, C2-ceramide (BIOMOL Research Laboratories, Inc.), and ABA (Panvera) were used at the concentrations indicated. The BLAST alignment tool was used for sequence comparisons (Altschul et al., 1997) .
Mutagenesis of NCR1
NCR1 deletions were constructed by allele replacement (Erdeniz et al., 1997) using a PCR product (oligos: 5Ј KONP', 3Ј KONP) homologous to NCR1 at its 5Ј and 3Ј ends and flanking the Kluyveromyces lactis URA3 gene. The locus was characterized by PCR with 5Ј and 3Ј NCR1 or URA3-specific oligos (5ЈNPSCR, 006INTSCR, 3Ј NP-internal', and 3ЈNPSCR). Missense alleles were created similarly with oligos N25, D25, and C25 for the NCR1Y 718 N, NCR1Y 718 D, and NCR1Y 571 C alleles, respectively. Ncr1p was tagged at the COOH terminus with a triple HA epitope (18 residues) using a PCR-generated template (Schneider et al., 1995) . All alleles were sequenced.
Expression of NCR1 in mammalian cells
NCR1 or NCR1-HA was amplified from yeast genomic DNA (oligos 5ЈNPSCR and 3ЈNPSCR) and incorporated into pCR3.1 digested with EcoRV (pCR3.1-NCR1 and pCR3.1-NCR1-HA). The COOH-terminal 53 residues of NCR1 were replaced with amino acids 1214-1278 of human NPC1 in pCR3.1-NCR1-Cterm after PCR amplification of the human cDNA (5ЈNCR1tail-BsmI and 3ЈNPC1tail), digestion with BsmI and XhoI, and ligation at the same sites in pCR3.1-NCR1.
CHO lines CT60 and NPC1-trap were cultured 3 d in Ham's F12 and 10% lipoprotein-deficient serum and transfected (FuGENE 6; Roche Molecular Biochemicals) with pCR3.1, pCR3.1-NCR1, or pCR3.1-NCR1-Cterm and a mammalian nuclear targeting-EGFP vector (Watari et al., 1999) to identify transfected cells. Cells were incubated with 10% lipoprotein-deficient serum and 50 g/ml of human LDL for 24 h, fixed with 3% PFA, and stained with 50 g/ml of filipin (Sigma-Aldrich). Cells were imaged by confocal fluorescence microscopy (model LSM510; Carl Zeiss MicroImaging, Inc.; excitation 488 nm for EGFP). For quantitative analysis, filipin-corrected cells were counted from multiple fields of EGFP-positive cells. For detection of GM1, cells were washed with Ham's F12, 25 mM Hepes, pH 7.4, and 0.01% BSA, incubated with 20 nM of Alexa 555-conjugated CtxB (Molecular Probes, Inc.) for 1 h at 37ЊC, and fixed with 4% PFA. Fluorescence images were collected after excitation at 568 nm using an microscope (model Axiomat 100; Carl Zeiss MicroImaging, Inc.).
Phenotypic analyses
The expression of NCR1-HA was confirmed in Triton X-100-soluble protein extracts (Guo et al., 2001 ) by immunoblotting with the 12CA5 mAb (Roche Molecular Biochemicals). Protein deglycosylation with endoglycosidase H was accomplished as directed (Roche Molecular Biochemicals). For growth in the presence of sphingosine (in ethanol) or ABA (in DMSO), cells were continuously monitored at 25ЊC at 600 nm using a microbiology reader (model Bioscreen C; ThermoLabsystems). BBL Gas Jars and GasPak Plus (Becton Dickinson) were used for anaerobic experiments (Tinkelenberg et al., 2000) . Growth tests on 2% potassium acetate, 3% ethanol, 0.8 M calcium chloride, 0.75 M sodium chloride, C2-ceramide (in 0.1% ethanol/0.05% tergitol), or 40 mM hydroxyurea were performed on solid YP media. Total RNA was isolated from independent isolates of the ncr1⌬ strain grown to OD 600 ϭ 0.5-0.6 in YEPD and analyzed in microarray or northern hybridizations (Wilcox et al., 2002 ; for 2-5 h), lysis, release of lipids, TLC, and data collection were performed as described previously (Yang et al., 1996) . Sphingolipids were isolated from cells treated with 5% TCA (ice, 15 min) by extraction with diethylether/ethanol/water/pyridine/ammonia (5:15:15:1:0.18, vol/vol) for 60 min at 60ЊC, resuspension was performed in chloroform/methanol/water (16:16:5) and TLC was performed on silica gel 60 (EM Science) plates resolved with chloroform/methanol/ 4.2N ammonia (9:7:2). Ergosterol localization was visualized by filipin staining (20 g/ml) as above.
Membrane Tinkelenberg et al., 2000) . 250-l fractions were diluted 10-fold with Tris EDTA buffer and centrifuged at 100,000 g. Radiolabeled sphingolipids were extracted from the pellet and resolved by TLC as before. 
Online supplemental material
All oligonucleotides were synthesized by Invitrogen and are described in Table S1 . Online supplemental material is available at http://www.jcb.org/ cgi/content/full/jcb.200310046/DC1.
